Enovis Corporation Gross Margin 2010-2024 | ENOV
Current and historical gross margin for Enovis Corporation (ENOV) over the last 10 years. The current gross profit margin for Enovis Corporation as of September 30, 2024 is %.
| Enovis Corporation Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-09-30 |
$2.00B |
$1.14B |
56.82% |
| 2024-06-30 |
$1.91B |
$1.09B |
57.16% |
| 2024-03-31 |
$1.82B |
$1.05B |
57.92% |
| 2023-12-31 |
$1.71B |
$0.99B |
57.96% |
| 2023-09-30 |
$1.66B |
$0.96B |
57.64% |
| 2023-06-30 |
$1.63B |
$0.93B |
57.19% |
| 2023-03-31 |
$1.59B |
$0.90B |
56.40% |
| 2022-12-31 |
$1.56B |
$0.87B |
55.66% |
| 2022-09-30 |
$0.99B |
$0.65B |
65.58% |
| 2022-06-30 |
$0.96B |
$0.63B |
65.35% |
| 2022-03-31 |
$0.92B |
$0.61B |
66.49% |
| 2021-12-31 |
$1.43B |
$0.78B |
54.56% |
| 2021-09-30 |
$0.47B |
$0.44B |
93.02% |
| 2021-06-30 |
$0.92B |
$0.59B |
63.76% |
| 2021-03-31 |
$1.18B |
$0.63B |
52.92% |
| 2020-12-31 |
$1.12B |
$0.60B |
53.84% |
| 2020-09-30 |
$3.13B |
$1.33B |
42.46% |
| 2020-06-30 |
$3.17B |
$1.35B |
42.67% |
| 2020-03-31 |
$3.46B |
$1.49B |
43.01% |
| 2019-12-31 |
$3.33B |
$1.40B |
42.10% |
| 2019-09-30 |
$2.67B |
$1.10B |
41.28% |
| 2019-06-30 |
$2.34B |
$0.90B |
38.57% |
| 2019-03-31 |
$2.00B |
$0.72B |
36.07% |
| 2018-12-31 |
$2.19B |
$0.73B |
33.29% |
| 2018-09-30 |
$1.48B |
$0.54B |
36.83% |
| 2018-06-30 |
$1.80B |
$0.64B |
35.43% |
| 2018-03-31 |
$2.09B |
$0.70B |
33.72% |
| 2017-12-31 |
$1.94B |
$0.67B |
34.67% |
| 2017-09-30 |
$3.01B |
$0.93B |
31.01% |
| 2017-06-30 |
$2.93B |
$0.91B |
30.95% |
| 2017-03-31 |
$3.04B |
$0.95B |
31.25% |
| 2016-12-31 |
$3.19B |
$0.99B |
31.14% |
| 2016-09-30 |
$3.13B |
$0.97B |
31.09% |
| 2016-06-30 |
$3.33B |
$1.03B |
30.94% |
| 2016-03-31 |
$3.40B |
$1.06B |
31.12% |
| 2015-12-31 |
$3.43B |
$1.07B |
31.19% |
| 2015-09-30 |
$4.11B |
$1.31B |
31.87% |
| 2015-06-30 |
$4.31B |
$1.39B |
32.21% |
| 2015-03-31 |
$4.48B |
$1.45B |
32.30% |
| 2014-12-31 |
$4.62B |
$1.48B |
31.99% |
| 2014-09-30 |
$4.59B |
$1.44B |
31.47% |
| 2014-06-30 |
$4.44B |
$1.39B |
31.34% |
| 2014-03-31 |
$4.31B |
$1.34B |
31.08% |
| 2013-12-31 |
$4.21B |
$1.31B |
31.04% |
| 2013-09-30 |
$4.06B |
$1.26B |
30.94% |
| 2013-06-30 |
$4.00B |
$1.23B |
30.61% |
| 2013-03-31 |
$3.97B |
$1.20B |
30.25% |
| 2012-12-31 |
$3.91B |
$1.15B |
29.47% |
| 2012-09-30 |
$3.06B |
$0.91B |
29.60% |
| 2012-06-30 |
$2.28B |
$0.68B |
29.82% |
| 2012-03-31 |
$1.42B |
$0.43B |
30.26% |
| 2011-12-31 |
$0.69B |
$0.24B |
34.73% |
| 2011-09-30 |
$0.68B |
$0.24B |
34.99% |
| 2011-06-30 |
$0.65B |
$0.23B |
34.88% |
| 2011-03-31 |
$0.58B |
$0.20B |
34.94% |
| 2010-12-31 |
$0.54B |
$0.19B |
35.42% |
| 2010-09-30 |
$0.51B |
$0.18B |
35.38% |
| 2010-06-30 |
$0.50B |
$0.18B |
35.39% |
| 2010-03-31 |
$0.51B |
$0.18B |
35.36% |
| 2009-12-31 |
$0.53B |
$0.19B |
35.43% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
